Axcella Health Inc. Common Stock
AXLA
AXLA was delisted on the 22nd of November, 2023.
35 hedge funds and large institutions have $50.4M invested in Axcella Health Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 9 reducing their positions, and 5 closing their positions.
5,880% more call options, than puts
Call options by funds: $299K | Put options by funds: $5K
0% more funds holding
Funds holding: 35 → 35 (0)
0% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 5
30% less capital invested
Capital invested by funds: $71.6M → $50.4M (-$21.2M)
33% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 9
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$311K |
| 2 |
Edgewood Management
Greenwich,
Connecticut
|
+$140K |
| 3 |
VF
Virtu Financial
New York
|
+$63K |
| 4 |
LC
Lindbrook Capital
Calabasas,
California
|
+$32.3K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$28.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
E
Ergoteles
New York
|
-$138K |
| 2 |
Marshall Wace
London,
United Kingdom
|
-$119K |
| 3 |
HF
HRT Financial
New York
|
-$110K |
| 4 |
CCB
Cutter & Co Brokerage
Ballwin,
Missouri
|
-$25.3K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$24.7K |
AXLA Hedge Fund Activity: Q4 2021 in Review
35 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Axcella Health Inc. Common Stock (AXLA) for Q4 2021, worth a combined $50.4M — down 30% from $71.6M a quarter earlier.
Fund positioning in AXLA was balanced in Q4 2021: 5 funds opened new positions, 5 closed out, 6 added to existing stakes and 9 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $311K. The largest seller was Ergoteles, exiting entirely with an estimated $138K sold.
- 35 institutional investors held Axcella Health Inc. Common Stock (AXLA) as of Q4 2021, unchanged from Q3 2021.
- Funds reported $50.4M of Axcella Health Inc. Common Stock stock for Q4 2021, down 30% quarter-over-quarter.
- 5 funds opened new Axcella Health Inc. Common Stock positions in Q4 2021 and 5 closed out, a net change of 0 holders.
- The largest Axcella Health Inc. Common Stock buyer in Q4 2021 was Fidelity Investments, an estimated $311K added.
- The largest Axcella Health Inc. Common Stock seller in Q4 2021 was Ergoteles, an estimated $138K sold.
Based on aggregated 13F filings for Q4 2021.